{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:47:00Z","timestamp":1766407620248},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Previously, we have reported that the human papillomavirus (HPV) type 16 E6 D25E is the most prevalent variant in Korean women at high risk for cervical cancers. Several studies have identified an association between the increased frequency of this variant and the elevated risk of cervical intraepithelial neoplasia and invasive cervical carcinoma. To investigate whether the HPV-16 E6 D25E variant might influence cervical cancer progression, we used an oligonucleotide microarray approach to identify transcriptionally altered gene expression patterns in recombinant wild-type E6 or E6 D25E variant-expressing HPV-negative cancer cells. We found that 211 genes were significantly up- or down-regulated (at least 1.5-fold, p &lt; 0.05). We identified 14 genes, nine down-regulated and five up-regulated upon E6 D25E expression, compared with wild-type E6 expression. These results further emphasize the unique biological activity of the HPV-16 E6 D25E variant.<\/jats:p>","DOI":"10.1186\/1743-422x-8-453","type":"journal-article","created":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T06:25:51Z","timestamp":1317104751000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Gene Expression Profiles are Altered in Human Papillomavirus-16 E6 D25E-Expressing Cell Lines"],"prefix":"10.1186","volume":"8","author":[{"given":"Mi","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JeeEun","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai-Ho","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Soon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,25]]},"reference":[{"key":"1568_CR1","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/j.1349-7006.2007.00546.x","volume":"98","author":"M Narisawa-Saito","year":"2007","unstructured":"Narisawa-Saito M, Kiyono T: Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins. Cancer Sci 2007, 98: 1505-1511. 10.1111\/j.1349-7006.2007.00546.x","journal-title":"Cancer Sci"},{"key":"1568_CR2","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1128\/JVI.75.9.4459-4466.2001","volume":"75","author":"Q Gao","year":"2001","unstructured":"Gao Q, Singh L, Kumar A, Srinivasan S, Wazer DE, Band V: Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells. J Virol 2001, 75: 4459-4466. 10.1128\/JVI.75.9.4459-4466.2001","journal-title":"J Virol"},{"key":"1568_CR3","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1038\/sj.onc.1202953","volume":"18","author":"M Thomas","year":"1999","unstructured":"Thomas M, Pim D, Banks L: The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 1999, 18: 7690-700. 10.1038\/sj.onc.1202953","journal-title":"Oncogene"},{"key":"1568_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/rmv.605","volume":"19","author":"T Yugawa","year":"2009","unstructured":"Yugawa T, Kiyono T: Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins. Rev Med Virol 2009, 19: 97-113. 10.1002\/rmv.605","journal-title":"Rev Med Virol"},{"key":"1568_CR5","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1128\/JVI.73.7.5887-5893.1999","volume":"73","author":"S Song","year":"1999","unstructured":"Song S, Pitot HC, Lambert PF: The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J Virol 1999, 73: 5887-5893.","journal-title":"J Virol"},{"key":"1568_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/(SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3","volume":"21","author":"P Londesborough","year":"1996","unstructured":"Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A: Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 1996, 21: 364-368.","journal-title":"Int J Cancer"},{"key":"1568_CR7","first-page":"829","volume":"58","author":"I Zehbe","year":"1998","unstructured":"Zehbe I, Wilander E, Delius H, Tommasino M: Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 1998, 58: 829-833.","journal-title":"Cancer Res"},{"key":"1568_CR8","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/S0140-6736(05)61263-9","volume":"352","author":"I Zehbe","year":"1998","unstructured":"Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M: Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 1998, 352: 1441-1442. 10.1016\/S0140-6736(05)61263-9","journal-title":"Lancet"},{"key":"1568_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0304-3835(00)00457-2","volume":"156","author":"K Matsumoto","year":"2000","unstructured":"Matsumoto K, Yoshikawa H, Nakagawa S, Tang X, Yasugi T, Kawana K, Sekiya S, Hirai Y, Kukimoto I, Kanda T, Taketani Y: Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett 2000, 156: 159-165. 10.1016\/S0304-3835(00)00457-2","journal-title":"Cancer Lett"},{"key":"1568_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejso.2009.07.186","volume":"36","author":"HB Cai","year":"2010","unstructured":"Cai HB, Chen CC, Ding XH: Human papillomavirus type 16 E6 gene variations in Chinese population. Eur J Surg Oncol 2010, 36: 160-163. 10.1016\/j.ejso.2009.07.186","journal-title":"Eur J Surg Oncol"},{"key":"1568_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/jmv.20826","volume":"79","author":"BS Choi","year":"2007","unstructured":"Choi BS, Kim SS, Yun H, Jang DH, Lee JS: Distinctive distribution of HPV16 E6 D25E and E7 N29S intratypic Asian variants in Korean commercial sex workers. J Med Virol 2007, 79: 426-430. 10.1002\/jmv.20826","journal-title":"J Med Virol"},{"key":"1568_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1099\/vir.0.81067-0","volume":"87","author":"AA Borb\u00e9ly","year":"2006","unstructured":"Borb\u00e9ly AA, Murvai M, K\u00f3nya J, Beck Z, Gergely L, Li F, Veress G: Effects of human papillomavirus type 16 oncoproteins on survivin gene expression. J Gen Virol 2006, 87: 287-294. 10.1099\/vir.0.81067-0","journal-title":"J Gen Virol"},{"key":"1568_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1048-891x.2005.15010.x","volume":"15","author":"S Kang","year":"2005","unstructured":"Kang S, Jeon YT, Kim JW, Park NH, Song YS, Kang SB, Lee HP: Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women. Int J Gynecol Cancer 2005, 15: 107-112. 10.1111\/j.1048-891x.2005.15010.x","journal-title":"Int J Gynecol Cancer"},{"key":"1568_CR14","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1128\/jvi.71.3.2463-2472.1997","volume":"71","author":"T Yamada","year":"1997","unstructured":"Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM: Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide prospective. J Virol 1997, 71: 2463-2472.","journal-title":"J Virol"},{"key":"1568_CR15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/ijc.21655","volume":"118","author":"HU Bernard","year":"2006","unstructured":"Bernard HU, Calleja-Macias IE, Dunn ST: Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 2006, 118: 1071-1076. 10.1002\/ijc.21655","journal-title":"Int J Cancer"},{"key":"1568_CR16","doi-asserted-by":"publisher","first-page":"5934","DOI":"10.1128\/JVI.78.11.5934-5945.2004","volume":"78","author":"O Chakrabarti","year":"2004","unstructured":"Chakrabarti O, Veeraraghavalu K, Tergaonkar V, Liu Y, Androphy EJ, Stanley MA, Krishna S: Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J Virol 2004, 78: 5934-5945. 10.1128\/JVI.78.11.5934-5945.2004","journal-title":"J Virol"},{"key":"1568_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.virol.2008.09.036","volume":"383","author":"I Zehbe","year":"2009","unstructured":"Zehbe I, Richard C, DeCarlo CA, Shai A, Lambert PF, Lichtig H, Tommasino M, Sherman L: Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Virology 2009, 383: 69-77. 10.1016\/j.virol.2008.09.036","journal-title":"Virology"},{"key":"1568_CR18","first-page":"3328","volume":"60","author":"LA Hansen","year":"2000","unstructured":"Hansen LA, Woodson RL, Holbus S, Strain K, Lo YC, Yuspa SH: The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors. Cancer Res 2000, 60: 3328-3332.","journal-title":"Cancer Res"},{"key":"1568_CR19","doi-asserted-by":"publisher","first-page":"30331","DOI":"10.1074\/jbc.M703713200","volume":"282","author":"M Gong","year":"2007","unstructured":"Gong M, Hay S, Marshall KR, Munro AW, Scrutton NS: DNA binding suppresses human AIF-M2 activity and provides a connection between redox chemistry reactive oxygen species, and apoptosis. J Biol Chem 2007, 282: 30331-30340. 10.1074\/jbc.M703713200","journal-title":"J Biol Chem"},{"key":"1568_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/jgm.1518","volume":"12","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Shi Y, Li X, Du W, Luo G, Gou Y, Wang X, Guo Z, Liu J, Ding J, Wu K, Fan D: Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer. J Gene Med 2010, 12: 147-156.","journal-title":"J Gene Med"},{"key":"1568_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s12672-010-0060-4","volume":"2","author":"K Fukasawa","year":"2011","unstructured":"Fukasawa K: Aberrant activation of cell cycle regulators, centrosome amplification, and mitotic defects. Horm Cancer 2011, 2: 104-112. 10.1007\/s12672-010-0060-4","journal-title":"Horm Cancer"},{"key":"1568_CR22","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1158\/1078-0432.CCR-06-0376","volume":"12","author":"CG Kleer","year":"2006","unstructured":"Kleer CG, Teknos TN, Islam M, Marcus B, Lee JS, Pan Q, Merjver SD: RhoC GTPase expression as a potential marker of lymphnode metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res 2006, 12: 4485-4490. 10.1158\/1078-0432.CCR-06-0376","journal-title":"Clin Cancer Res"},{"key":"1568_CR23","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/hep.22836","volume":"49","author":"CC Wong","year":"2009","unstructured":"Wong CC, Wong CM, Tung EK, Man K, NG IO: Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion. Hepatology 2009, 49: 1583-1594. 10.1002\/hep.22836","journal-title":"Hepatology"},{"key":"1568_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0168-1702(02)00191-0","volume":"89","author":"A Hildesheim","year":"2002","unstructured":"Hildesheim A, Wang SS: Host and viral genetics and risk of cervical cancer: a review. Virus Res 2002, 89: 229-240. 10.1016\/S0168-1702(02)00191-0","journal-title":"Virus Res"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-453.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T17:01:44Z","timestamp":1630515704000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,25]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1568"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-453","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,25]]},"assertion":[{"value":"13 July 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"453"}}